- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
Trametinib – March 2014
TRAMETINIB, 0.5 mg tablet, 30 and 2 mg tablet, 30 Mekinist® GlaxoSmithKline Australia Pty Ltd
Last updated
8 November 2023
